Single-Dose Vaginal Treatment for Yeast Infections
For uncomplicated yeast infections, use either tioconazole 6.5% ointment 5g as a single intravaginal application OR clotrimazole 500mg vaginal tablet as a single dose—both are equally effective and recommended by CDC guidelines. 1, 2
Understanding Single-Dose Options
The CDC guidelines explicitly list two single-dose intravaginal azole options for uncomplicated vulvovaginal candidiasis:
- Tioconazole 6.5% ointment (5g single application) - Available over-the-counter
- Clotrimazole 500mg vaginal tablet (one tablet single application) - Available over-the-counter
Both achieve 80-90% cure rates in uncomplicated cases 1. These single-dose treatments are specifically appropriate for mild-to-moderate, sporadic, nonrecurrent disease in otherwise healthy women with C. albicans infection 1.
When Single-Dose Treatment Works Best
Single-dose vaginal therapy is most effective when:
- Symptoms are mild to moderate (not severe vulvar swelling or extensive erythema)
- First episode or infrequent recurrence (not 3+ episodes per year)
- No underlying conditions like uncontrolled diabetes or immunosuppression
- Confirmed or suspected C. albicans (not non-albicans species like C. glabrata)
Important Clinical Caveats
Avoid single-dose treatment if:
- Severe symptoms present (extensive vulvar edema, fissures, excoriation)
- Recurrent VVC (≥4 episodes/year) - these require 10-14 day regimens 1
- Pregnancy - only 7-day topical azole regimens should be used 1
- Suspected non-albicans species - longer therapy needed 1
Practical Considerations
Oil-based formulations: Both tioconazole and clotrimazole preparations are oil-based and may weaken latex condoms and diaphragms 1, 3. Counsel patients accordingly.
OTC availability: The convenience of over-the-counter access makes these attractive first-line options, but emphasize that self-treatment should only occur in women with previously diagnosed VVC experiencing identical symptoms 1, 2.
Follow-up threshold: Instruct patients to seek medical care if symptoms persist after treatment or recur within 2 months 1, 3.
Alternative Single-Dose Consideration
While not intravaginal, fluconazole 150mg oral tablet as a single dose is also highly effective and may be preferred by some patients for convenience 1. Recent network meta-analysis suggests single-dose oral fluconazole may have marginally superior early clinical cure rates compared to topical therapy 4, though both routes achieve excellent outcomes in uncomplicated cases.
Between the two intravaginal single-dose options, there is no evidence favoring one over the other—choose based on patient preference and availability.